{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,10,15]],"date-time":"2024-10-15T20:40:28Z","timestamp":1729024828122},"reference-count":21,"publisher":"Bentham Science Publishers Ltd.","issue":"1","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CDS"],"published-print":{"date-parts":[[2024,2]]},"abstract":"<jats:sec><jats:title>Background:<\/jats:title><jats:p>Adverse drug reactions (ADR) are considered any harmful and unintended side effects associated with the use of a drug at the usual therapeutic dose, in which skin is involved in most cases. Therefore, the availability of epidemiological information on reactions, reaction patterns, and their causative drugs can be helpful in timely diagnosis and necessary measures, such as caution in prescribing causative drugs to prevent these types of reactions.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods:<\/jats:title><jats:p>In this retrospective descriptive study, the archived files of patients with dermatoses due to ADR referred to Taleghani University Hospital, Urmia, Iran, during 2015-2020 were studied. Patterns and frequency of skin reactions, demographic data, and the frequency of chronic comorbidities were identified.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results:<\/jats:title><jats:p>A total of 50 patients with drug-induced skin rash were found, of which 14 were male (28%) and 36 were female (72%). Skin rashes were most frequently found in patients aged 31-40 years. In 76% of patients, there was at least one chronic underlying disease. The most common reaction pattern was maculopapular rash (44%), and the most common causative drugs were antiepileptic drugs (34%) and antibiotics (22%). Mortality was found in 4 cases, which was due to antibiotics and antiepileptic drugs that caused toxic SJS\/TEN and erythroderma. The hospital stays were highest in SJS and lowest in a maculopapular rash.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion:<\/jats:title><jats:p>Knowledge about the epidemiology and the frequency of adverse drug reactions may be helpful in increasing the awareness of physicians for correct and rational drug prescriptions, which can reduce unnecessary hospital referrals and treatment costs.<\/jats:p><\/jats:sec>","DOI":"10.2174\/1574886318666230303085538","type":"journal-article","created":{"date-parts":[[2023,3,6]],"date-time":"2023-03-06T04:04:28Z","timestamp":1678075468000},"page":"117-122","update-policy":"http:\/\/dx.doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Cutaneous Adverse Drug Reactions: Regional Experience of a Global Challenge"],"prefix":"10.2174","volume":"19","author":[{"given":"Behzad","family":"Bushehri","sequence":"first","affiliation":[{"name":"Department of Forensic Medicine and Toxicology, School of Medicine, Urmia University of Medical Sciences, Urmia, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akbar","family":"Mokhtarpoor","sequence":"additional","affiliation":[{"name":"Department of Forensic Medicine and Toxicology, School of Medicine, Urmia University of Medical Sciences, Urmia, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ehsan","family":"Bahrami","sequence":"additional","affiliation":[{"name":"Department of Forensic Medicine and Toxicology, School of Medicine, Urmia University of Medical Sciences, Urmia, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adel","family":"Ghorani-Azam","sequence":"additional","affiliation":[{"name":"Department of Forensic Medicine and Toxicology, School of Medicine, Urmia University of Medical Sciences, Urmia, Iran"},{"name":"Food and Beverages Safety Research Center, Urmia University of Medical Sciences, Urmia, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s11882-018-0778-6","volume":"18","author":"Mustafa S.S.","year":"2018","unstructured":"Mustafa S.S.; Ostrov D.; Yerly D.; Severe cutaneous adverse drug reactions: Presentation, risk factors, and management. Curr Allergy Asthma Rep 2018,18(4),26","journal-title":"Curr Allergy Asthma Rep"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1111\/ced.12572","volume":"40","author":"Ferner R.E.","year":"2015","unstructured":"Ferner R.E.; Adverse drug reactions in dermatology. Clin Exp Dermatol 2015,40(2),105-110","journal-title":"Clin Exp Dermatol"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s40291-018-0330-3","volume":"22","author":"Gerogianni K.","year":"2018","unstructured":"Gerogianni K.; Tsezou A.; Dimas K.; Drug-induced skin adverse reactions: The role of pharmacogenomics in their prevention. Mol Diagn Ther 2018,22(3),297-314","journal-title":"Mol Diagn Ther"},{"key":"ref=4a","first-page":"53","volume":"8","author":"Farshchian M.","year":"2015","unstructured":"Farshchian M.; Ansar A.; Zamanian A.; Rahmatpour-Rokni G.; Kimyai-Asadi A.; Farshchian M.; Drug-induced skin reactions: A 2-year study. Clin Cosmet Investig Dermatol 2015,8,53-56","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"ref=4b","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/j.jaad.2015.07.017","volume":"73","author":"Szatkowski J.","year":"2015","unstructured":"Szatkowski J.; Schwartz R.A.; Acute generalized exanthematous pustulosis (AGEP): A review and update. J Am Acad Dermatol 2015,73(5),843-848","journal-title":"J Am Acad Dermatol"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s00281-015-0540-2","volume":"38","author":"Hoetzenecker W.","year":"2016","unstructured":"Hoetzenecker W.; N\u00e4geli M.; Mehra E.T.; Adverse cutaneous drug eruptions: Current understanding. Semin Immunopathol 2016,38(1),75-86","journal-title":"Semin Immunopathol"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1007\/s40266-014-0209-x","volume":"31","author":"Tuchinda P.","year":"2014","unstructured":"Tuchinda P.; Chularojanamontri L.; Sukakul T.; Cutaneous adverse drug reactions in the elderly: A retrospective analysis in Thailand. Drugs Aging 2014,31(11),815-824","journal-title":"Drugs Aging"},{"key":"ref=7a","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.jsps.2013.02.003","volume":"22","author":"Alomar M.J.","year":"2014","unstructured":"Alomar M.J.; Factors affecting the development of adverse drug reactions (Review article). Saudi Pharm J 2014,22(2),83-94","journal-title":"Saudi Pharm J"},{"key":"ref=7b","doi-asserted-by":"publisher","first-page":"174","DOI":"10.2174\/1871527319666201207205916","volume":"20","author":"Ghorani-Azam A.","year":"2021","unstructured":"Ghorani-Azam A.; Balali-Mood M.; Riahi-Zanjani B.; Darchini-Maragheh E.; Sadeghi M.; Acute phenobarbital poisoning for the management of seizures in newborns and children; A systematic literature review. CNS Neurol Disord Drug Targets 2021,20(2),174-180","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"316","DOI":"10.2174\/1871527320666210811162345","volume":"21","author":"Riahi-Zanjani B.","year":"2022","unstructured":"Riahi-Zanjani B.; Delirrad M.; Fazeli-Bakhtiyari R.; Hematological consequences of valproic acid in pediatric patients: A systematic review with a mechanistic approach. CNS Neurol Disord Drug Targets 2022,21(4),316-325","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.jbi.2015.11.005","volume":"59","author":"White R.W.","year":"2016","unstructured":"White R.W.; Wang S.; Pant A.; Early identification of adverse drug reactions from search log data. J Biomed Inform 2016,59,42-48","journal-title":"J Biomed Inform"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"S166","DOI":"10.1016\/0926-9959(95)96455-H","volume":"5","author":"Rademaker M.","year":"1995","unstructured":"Rademaker M.; Oakley A.; Duffill M.B.; Cutaneous adverse drug reactions in a hospital setting. J Eur Acad Dermatol Venereol 1995,5(1),S166","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1007\/s11096-015-0161-9","volume":"37","author":"Chopra D.","year":"2015","unstructured":"Chopra D.; Sharma V.; Kapoor R.; Dwivedi S.; An observational study of cutaneous adverse drug reactions in a teaching hospital. Int J Clin Pharm 2015,37(6),996-999","journal-title":"Int J Clin Pharm"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1016\/j.abd.2019.01.007","volume":"94","author":"Zhao J.","year":"2019","unstructured":"Zhao J.; Hu L.; Zhang L.; Zhou M.; Gao L.; Cheng L.; Causative drugs for drug-induced cutaneous reactions in central China: A 608-case analysis. An Bras Dermatol 2019,94(6),664-670","journal-title":"An Bras Dermatol"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"36","DOI":"10.23822\/EurAnnACI.1764-1489.23","volume":"50","author":"B\u00fcy\u00fck\u00f6zt\u00fcrk S.","year":"2018","unstructured":"B\u00fcy\u00fck\u00f6zt\u00fcrk S.; Kekik \u00c7.; G\u00f6kyi\u011fit A.Z.; Cutaneous drug reactions to antiepileptic drugs and relation with HLA alleles in the Turkish population. Eur Ann Allergy Clin Immunol 2018,50(1),36-41","journal-title":"Eur Ann Allergy Clin Immunol"},{"key":"ref=14","first-page":"151","volume":"72","author":"Latha S.","year":"2017","unstructured":"Latha S.; Choon S.E.; Incidence of cutaneous adverse drug reactions among medical inpatients of Sultanah Aminah Hospital Johor Bahru. Med J Malaysia 2017,72(3),151-156","journal-title":"Med J Malaysia"},{"key":"ref=15","doi-asserted-by":"crossref","first-page":"11","DOI":"10.4103\/2231-4040.70513","volume":"1","author":"Bhattacharya S.","year":"2010","unstructured":"Bhattacharya S.; The facts about penicillin allergy: A review. J Adv Pharm Technol Res 2010,1(1),11-17","journal-title":"J Adv Pharm Technol Res"},{"key":"ref=16a","doi-asserted-by":"publisher","first-page":"NP102","DOI":"10.1093\/asj\/sju105","volume":"35","author":"Careta M.F.","year":"2015","unstructured":"Careta M.F.; Delgado L.; Patriota R.; Report of allergic reaction after application of botulinum toxin. Aesthet Surg J 2015,35(5),NP102-NP105","journal-title":"Aesthet Surg J"},{"key":"ref=16b","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1177\/1090820X14532648","volume":"34","author":"Rosenfield L.K.","year":"2014","unstructured":"Rosenfield L.K.; Kardassakis D.G.; Tsia K.A.; Stayner G.; The first case report of a systemic allergy to on a botulinum toxina (botox) in a healthy patient. Aesthet Surg J 2014,34(5),766-768","journal-title":"Aesthet Surg J"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"250","DOI":"10.4103\/ijd.IJD_682_16","volume":"64","author":"Modi A.","year":"2019","unstructured":"Modi A.; Desai M.; Shah S.; Shah B.; Analysis of cutaneous adverse drug reactions reported at the regional ADR monitoring center. Indian J Dermatol 2019,64(3),250","journal-title":"Indian J Dermatol"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"76","DOI":"10.4103\/2229-5178.146165","volume":"5","author":"Patel T.","year":"2014","unstructured":"Patel T.; Thakkar S.; Sharma D.C.; Cutaneous adverse drug reactions in Indian population: A systematic review. Indian Dermatol Online J 2014,5(6)(Suppl 2),76","journal-title":"Indian Dermatol Online J"}],"container-title":["Current Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1574886318666230303085538","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/214318\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1574886318666230303085538","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,15]],"date-time":"2024-10-15T20:06:37Z","timestamp":1729022797000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/214318\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1574886318666230303085538","relation":{},"ISSN":["1574-8863"],"issn-type":[{"type":"print","value":"1574-8863"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2022-09-05","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-12-11","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-01-18","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-11-02","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}